Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
298
Appointments
152
Departures
30
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,410 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Humacyte, Inc. | Paul Kuznik | Class II directorClass II director | Appointed | Sep 22, 2026 | SEC 8-K |
| Sep 28, 2026 | Jasper Therapeutics, Inc. | Herb Cross | Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer and Corporate SecretaryCFO | Departed | Oct 9, 2026 | SEC 8-K |
| Sep 28, 2026 | Jasper Therapeutics, Inc. | Jeet Mahal | interim Principal Financial Officerinterim Principal Financial Officer | Appointed | Oct 9, 2026 | SEC 8-K |
| Sep 28, 2026 | Jasper Therapeutics, Inc. | Rick Ruiz | interim Principal Accounting Officerinterim Principal Accounting Officer | Appointed | Oct 9, 2026 | SEC 8-K |
| Sep 28, 2026 | Jasper Therapeutics, Inc. | Matthew Ros | interim Corporate Secretaryinterim Corporate Secretary | Appointed | Oct 9, 2026 | SEC 8-K |
| Sep 28, 2026 | Matternet, Inc. | Jason Secore | Chief Financial OfficerCFO | Departed | Sep 29, 2026 | SEC 8-K |
| Sep 28, 2026 | Matternet, Inc. | Andreas Raptopoulos | Chief Financial OfficerCFO | Appointed | Sep 29, 2026 | SEC 8-K |
| Sep 28, 2026 | MongoDB, Inc. | Chirantan (“CJ”) Desai | President and Chief Executive OfficerCEO | Departed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | MongoDB, Inc. | Dev Ittycheria | Interim President and Chief Executive OfficerCEO | Appointed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | NEUROCRINE BIOSCIENCES INC | Eiry W. Roberts, M.D. | Chief Medical OfficerCMO | Appointed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | NEUROCRINE BIOSCIENCES INC | Sanjay Keswani, M.D. | Chief Medical OfficerCMO | Departed | Sep 25, 2026 | SEC 8-K |
| Sep 28, 2026 | QUANTUM CORP /DE/ | James C. Clancy | Chief Operating OfficerCOO | Appointed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | QUANTUM CORP /DE/ | James C. Clancy | member of the Company’s Board of Directorsmember of the Company’s Board of Directors | Departed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | StandardAero, Inc. | Kimberly Ernzen | Chief Operating OfficerCOO | Departed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | SURF AIR MOBILITY INC. | Jason Secore | Chief Financial OfficerCFO | Appointed | Sep 30, 2026 | SEC 8-K |
| Sep 28, 2026 | SURF AIR MOBILITY INC. | Oliver Reeves | Chief Financial OfficerCFO | Departed | Sep 30, 2026 | SEC 8-K |
| Sep 28, 2026 | TELEDYNE TECHNOLOGIES INC | Jason VanWees | Vice ChairmanVice Chairman | Departed | Feb 1, 2027 | SEC 8-K |
| Sep 28, 2026 | Tempest Therapeutics, Inc. | Nancy Freda-Smith | Class III directorClass III director | Appointed | Sep 22, 2026 | SEC 8-K |
| Sep 28, 2026 | Tempest Therapeutics, Inc. | Nicholas Rossettos | Chief Financial OfficerCFO | Departed | Sep 22, 2026 | SEC 8-K |
| Sep 28, 2026 | Tempest Therapeutics, Inc. | Constance Ames | Chief Financial Officer Principal Financial and Accounting Officer, Treasurer, and Corporate SecretaryCFO | Appointed | Sep 22, 2026 | SEC 8-K |
- Humacyte, Inc.Appointed
Paul Kuznik Class II director
Filed Sep 28, 2026Effective Sep 22, 2026SEC 8-K
- Jasper Therapeutics, Inc.Departed
Herb Cross CFO
Filed Sep 28, 2026Effective Oct 9, 2026SEC 8-K
- Jasper Therapeutics, Inc.Appointed
Jeet Mahal interim Principal Financial Officer
Filed Sep 28, 2026Effective Oct 9, 2026SEC 8-K
- Jasper Therapeutics, Inc.Appointed
Rick Ruiz interim Principal Accounting Officer
Filed Sep 28, 2026Effective Oct 9, 2026SEC 8-K
- Jasper Therapeutics, Inc.Appointed
Matthew Ros interim Corporate Secretary
Filed Sep 28, 2026Effective Oct 9, 2026SEC 8-K
- Matternet, Inc.Departed
Jason Secore CFO
Filed Sep 28, 2026Effective Sep 29, 2026SEC 8-K
- Matternet, Inc.Appointed
Andreas Raptopoulos CFO
Filed Sep 28, 2026Effective Sep 29, 2026SEC 8-K
- MongoDB, Inc.Departed
Chirantan (“CJ”) Desai CEO
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- MongoDB, Inc.Appointed
Dev Ittycheria CEO
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- NEUROCRINE BIOSCIENCES INCAppointed
Eiry W. Roberts, M.D. CMO
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- NEUROCRINE BIOSCIENCES INCDeparted
Sanjay Keswani, M.D. CMO
Filed Sep 28, 2026Effective Sep 25, 2026SEC 8-K
- QUANTUM CORP /DE/Appointed
James C. Clancy COO
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- QUANTUM CORP /DE/Departed
James C. Clancy member of the Company’s Board of Directors
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- StandardAero, Inc.Departed
Kimberly Ernzen COO
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- SURF AIR MOBILITY INC.Appointed
Jason Secore CFO
Filed Sep 28, 2026Effective Sep 30, 2026SEC 8-K
- SURF AIR MOBILITY INC.Departed
Oliver Reeves CFO
Filed Sep 28, 2026Effective Sep 30, 2026SEC 8-K
- TELEDYNE TECHNOLOGIES INCDeparted
Jason VanWees Vice Chairman
Filed Sep 28, 2026Effective Feb 1, 2027SEC 8-K
- Tempest Therapeutics, Inc.Appointed
Nancy Freda-Smith Class III director
Filed Sep 28, 2026Effective Sep 22, 2026SEC 8-K
- Tempest Therapeutics, Inc.Departed
Nicholas Rossettos CFO
Filed Sep 28, 2026Effective Sep 22, 2026SEC 8-K
- Tempest Therapeutics, Inc.Appointed
Constance Ames CFO
Filed Sep 28, 2026Effective Sep 22, 2026SEC 8-K